Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30.84 USD | -2.14% | +5.61% | -7.91% |
May. 10 | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
May. 08 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.91% | 1.47B | |
+32.39% | 694B | |
+29.39% | 593B | |
-1.38% | 371B | |
+20.00% | 331B | |
+7.23% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.45% | 169B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Insider Trends: Pacira Biosciences Insider Continues 90-Day Selling Trend